You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1-like

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in France, Netherlands (ddAC-CP-Olaparib, ddAC-mini CTC)

Recruiting
  • Breast Cancer
  • Marseille, France
  • +10 more
Oct 11, 2022

Ultra-rapid BRCA1/2 Status Screening Test in Theranostic

Not yet recruiting
  • Breast Cancer
  • Questionnaires
  • Communication of the results of the BRCA1/2 ultra rapid test
  • (no location specified)
Oct 26, 2023

BRCA1/2 Flu Vaccine

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 16, 2022

Germline Variant Carriers With BRCA1 or BRCA2

Recruiting
  • BRCA1 and/or BRCA2 Variant Carriers
  • +3 more
    • Okayama, Japan
      Okayama University
    Dec 25, 2022

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

    Recruiting
    • Breast Cancer
    • Genetic Predisposition
    • Genetic predisposition to breast cancer
    • Rome, Italy
    • +1 more
    May 4, 2023

    Endocrine Disruptors and Life STILe in Breast Cancer Development

    Recruiting
    • Breast Cancer
    • +5 more
      • Roma, Italy
        Alessandra Fabi
      Feb 25, 2023

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

      Active, not recruiting
      Has Results
      • BRCA1 Gene Mutation
      • +5 more
      • Durvalumab
      • +3 more
      • Buffalo, New York
      • +1 more
      Jan 20, 2023

      Cystatin D Fibrinogen Like Protein 1

      Not yet recruiting
      • Fibrinogen Like Protein 1
      • ELISA TEST
      • (no location specified)
      Jun 26, 2023

      Breast Cancer BRCA1 Carriers: a Pilot Study

      Withdrawn
      • BRCA1 Mutation
      • +2 more
      • Mifepristone 200 MG
      • Prophylactic mastectomy
      • Carmel, Indiana
      • +1 more
      Dec 13, 2022

      BRCA and NACT in TNBC Patients

      Completed
      • Triple-Negative Breast Cancer
      • BRCA1/2 genetic testing
      • Rome, RM, Italy
        Fondazione Policlinico Universitario Agostino Gemelli IRCCS
      Feb 20, 2023

      Breast Cancer Trial in Tucson, Albuquerque (Pegylated liposomal doxorubicin)

      Completed
      • Breast Cancer
      • Pegylated liposomal doxorubicin
      • Tucson, Arizona
      • +1 more
      Jan 9, 2023

      Breast Cancer, Breast Cancer Metastatic Trial in Spain (Niraparib 100 MG, Aromatase Inhibitors)

      Terminated
      • Breast Cancer
      • Breast Cancer Metastatic
      • Niraparib 100 MG
      • Aromatase Inhibitors
      • A Coruña, Spain
      • +9 more
      Jan 17, 2023

      Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))

      Completed
      Has Results
      • Breast Neoplasms
      • KU-0059436 (AZD2281) (PARP inhibitor)
      • West Hollywood, California
      • +16 more
      Jan 24, 2023

      Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

      Not yet recruiting
      • Pancreatic Acinar Cell Carcinoma
      • +6 more
      • Nab paclitaxel
      • +5 more
      • (no location specified)
      Oct 30, 2023

      PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

      Not yet recruiting
      • BRCA Mutation
      • +2 more
      • Germinal BRCA
      • (no location specified)
      Mar 3, 2023

      Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

      Not yet recruiting
      • Breast Cancer
      • +7 more
      • (no location specified)
      Sep 26, 2023

      Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

      Not yet recruiting
      • Prostate Adenocarcinoma
      • +2 more
      • Biospecimen Collection
      • +6 more
      • (no location specified)
      Mar 28, 2023

      Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

      Not yet recruiting
      • Prostate Cancer
      • +4 more
      • (no location specified)
      Aug 10, 2022

      Insulin Like Growth Factor-1 Against Oxidative Stress in

      Not yet recruiting
      • Vitiligo
      • skin biopsy examined by ELISA technique
      • (no location specified)
      Apr 13, 2023

      Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

      Active, not recruiting
      • Hereditary Breast and Ovarian Cancer
      • Structured exercise training plus mediterranean diet
      • Cologne, Germany
      • +2 more
      Oct 25, 2022

      InheriteD brEast caNcer iTalian regIsTrY A

      Recruiting
      • Breast Cancer
        • Aviano, Pordenone, Italy
        • +11 more
        Apr 26, 2023

        Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

        Not yet recruiting
        • Overweight and Obesity
        • 24-hour ambulatory blood pressure
        • Liberal salt diet
        • (no location specified)
        Oct 4, 2023

        Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

        Recruiting
        • Hereditary Breast and Ovarian Cancer
          • Barcelona, Spain
            Hospital de la Santa Creu i Sant Pau
          Jun 3, 2022

          Mesothelioma, Malignant Mesothelioma (MM), Early-stage Mesothelioma Trial run by the National Cancer Institute (NCI)

          Not yet recruiting
          • Mesothelioma
          • +5 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Aug 1, 2023